TRINITY MEDICAL GROUP INC
10QSB/A, EX-27, 2000-09-06
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: TRINITY MEDICAL GROUP INC, 10QSB/A, 2000-09-06
Next: TEMPLE SUMMIT FINANCIAL PROJECTS INC/NV, 8-K/A, EX-99.1, 2000-09-06



<TABLE> <S> <C>

<ARTICLE>                     5

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                              DEC-31-2000
<PERIOD-START>                                 JAN-01-2000
<PERIOD-END>                                   JUN-30-2000
<CASH>                                         33,303
<SECURITIES>                                   0
<RECEIVABLES>                                  18,951
<ALLOWANCES>                                   0
<INVENTORY>                                    0
<CURRENT-ASSETS>                               52,254
<PP&E>                                         2,100
<DEPRECIATION>                                 0
<TOTAL-ASSETS>                                 54,534
<CURRENT-LIABILITIES>                          127,348
<BONDS>                                        0
                          0
                                    34,500
<COMMON>                                       10,226
<OTHER-SE>                                     (845,494)
<TOTAL-LIABILITY-AND-EQUITY>                   54,354
<SALES>                                        0
<TOTAL-REVENUES>                               0
<CGS>                                          216,409
<TOTAL-COSTS>                                  36,183
<OTHER-EXPENSES>                               0
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             37,303
<INCOME-PRETAX>                                (252,592)
<INCOME-TAX>                                   0
<INCOME-CONTINUING>                            0
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   (252,592)
<EPS-BASIC>                                    (0.02)
<EPS-DILUTED>                                  (0.02)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission